CVS Health shares climbed Tuesday after the health conglomerate hiked its full-year outlook and outlined plans for a new AI ...

Key opportunities in the market include leveraging CRISPR's precision for improved crop traits, meeting food security demands amid climate change, and sustainable agriculture trendsDublin, Dec. 09, ...

Cathie Wood, chief of Ark Investment Management, is making moves in megacap tech stocks. Last month, Wood added to her ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

Despite a challenging CASGEVY launch, high cash burn, and an almost 10% YTD share count growth, CRISPR’s pipeline breadth and ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...

To compile our list of the best short squeeze stocks, we made use of stocks screeners to note down stocks with significant ...

Fintel reports that on November 26, 2025, Chardan Capital maintained coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...

These stocks have market caps of around $4 billion and $5 billion, and they could potentially double or triple in size in the long run.

(NEXSTAR) – The predictions are in for winter weather – and they are very different depending on where you live. The Climate Prediction Center, a division of the National Oceanic and Atmospheric ...